High level of telomerase RNA gene expression is associated with chromatin modification, the ALT phenotype and poor prognosis in liposarcoma

C. J. Cairney, S. F. Hoare, M. G. Daidone, N. Zaffaroni, W. N. Keith

Research output: Contribution to journalArticle

Abstract

Telomere length is maintained by two known mechanisms, activation of telomerase or alternative lengthening of telomeres (ALT). The ALT pathway is more commonly activated in tumours of mesenchymal origin, although the mechanisms involved in the decision of a cell to activate either telomerase or ALT are unknown at present and no molecular markers exist to define the ALT phenotype. We have previously shown an association between chromatin remodelling, telomerase gene expression and ALT in cell line models. Here, we evaluate these findings and investigate their prognostic significance in a panel of liposarcoma tissue samples to understand the biology underlying the ALT phenotype. Liposarcoma samples were split into three groups: telomerase positive (Tel+); ALT positive; ALT-/Tel-. Differences in telomerase gene expression were evident between the groups with increased expression of hTR in ALT and Tel+ compared to ALT-/Tel- samples and increased hTERT in Tel+ samples only. Investigation of a small panel of chromatin modifications revealed significantly increased binding of acetyl H3 in association with hTR expression. We confirm that the presence of the ALT phenotype is associated with poor prognosis and in addition, for the first time, we show a direct association between hTR expression and poor prognosis in liposarcoma patients.

Original languageEnglish
Pages (from-to)1467-1474
Number of pages8
JournalBritish Journal of Cancer
Volume98
Issue number8
DOIs
Publication statusPublished - Apr 22 2008

Fingerprint

Telomere Homeostasis
Liposarcoma
Chromatin
Phenotype
Gene Expression
Telomerase
telomerase RNA
Chromatin Assembly and Disassembly
Telomere

Keywords

  • ALT
  • Chromatin
  • hTERT
  • hTR
  • Liposarcoma
  • Telomerase

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

High level of telomerase RNA gene expression is associated with chromatin modification, the ALT phenotype and poor prognosis in liposarcoma. / Cairney, C. J.; Hoare, S. F.; Daidone, M. G.; Zaffaroni, N.; Keith, W. N.

In: British Journal of Cancer, Vol. 98, No. 8, 22.04.2008, p. 1467-1474.

Research output: Contribution to journalArticle

@article{e806283bfa6f40e1b037481f10ed7bfe,
title = "High level of telomerase RNA gene expression is associated with chromatin modification, the ALT phenotype and poor prognosis in liposarcoma",
abstract = "Telomere length is maintained by two known mechanisms, activation of telomerase or alternative lengthening of telomeres (ALT). The ALT pathway is more commonly activated in tumours of mesenchymal origin, although the mechanisms involved in the decision of a cell to activate either telomerase or ALT are unknown at present and no molecular markers exist to define the ALT phenotype. We have previously shown an association between chromatin remodelling, telomerase gene expression and ALT in cell line models. Here, we evaluate these findings and investigate their prognostic significance in a panel of liposarcoma tissue samples to understand the biology underlying the ALT phenotype. Liposarcoma samples were split into three groups: telomerase positive (Tel+); ALT positive; ALT-/Tel-. Differences in telomerase gene expression were evident between the groups with increased expression of hTR in ALT and Tel+ compared to ALT-/Tel- samples and increased hTERT in Tel+ samples only. Investigation of a small panel of chromatin modifications revealed significantly increased binding of acetyl H3 in association with hTR expression. We confirm that the presence of the ALT phenotype is associated with poor prognosis and in addition, for the first time, we show a direct association between hTR expression and poor prognosis in liposarcoma patients.",
keywords = "ALT, Chromatin, hTERT, hTR, Liposarcoma, Telomerase",
author = "Cairney, {C. J.} and Hoare, {S. F.} and Daidone, {M. G.} and N. Zaffaroni and Keith, {W. N.}",
year = "2008",
month = "4",
day = "22",
doi = "10.1038/sj.bjc.6604328",
language = "English",
volume = "98",
pages = "1467--1474",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - High level of telomerase RNA gene expression is associated with chromatin modification, the ALT phenotype and poor prognosis in liposarcoma

AU - Cairney, C. J.

AU - Hoare, S. F.

AU - Daidone, M. G.

AU - Zaffaroni, N.

AU - Keith, W. N.

PY - 2008/4/22

Y1 - 2008/4/22

N2 - Telomere length is maintained by two known mechanisms, activation of telomerase or alternative lengthening of telomeres (ALT). The ALT pathway is more commonly activated in tumours of mesenchymal origin, although the mechanisms involved in the decision of a cell to activate either telomerase or ALT are unknown at present and no molecular markers exist to define the ALT phenotype. We have previously shown an association between chromatin remodelling, telomerase gene expression and ALT in cell line models. Here, we evaluate these findings and investigate their prognostic significance in a panel of liposarcoma tissue samples to understand the biology underlying the ALT phenotype. Liposarcoma samples were split into three groups: telomerase positive (Tel+); ALT positive; ALT-/Tel-. Differences in telomerase gene expression were evident between the groups with increased expression of hTR in ALT and Tel+ compared to ALT-/Tel- samples and increased hTERT in Tel+ samples only. Investigation of a small panel of chromatin modifications revealed significantly increased binding of acetyl H3 in association with hTR expression. We confirm that the presence of the ALT phenotype is associated with poor prognosis and in addition, for the first time, we show a direct association between hTR expression and poor prognosis in liposarcoma patients.

AB - Telomere length is maintained by two known mechanisms, activation of telomerase or alternative lengthening of telomeres (ALT). The ALT pathway is more commonly activated in tumours of mesenchymal origin, although the mechanisms involved in the decision of a cell to activate either telomerase or ALT are unknown at present and no molecular markers exist to define the ALT phenotype. We have previously shown an association between chromatin remodelling, telomerase gene expression and ALT in cell line models. Here, we evaluate these findings and investigate their prognostic significance in a panel of liposarcoma tissue samples to understand the biology underlying the ALT phenotype. Liposarcoma samples were split into three groups: telomerase positive (Tel+); ALT positive; ALT-/Tel-. Differences in telomerase gene expression were evident between the groups with increased expression of hTR in ALT and Tel+ compared to ALT-/Tel- samples and increased hTERT in Tel+ samples only. Investigation of a small panel of chromatin modifications revealed significantly increased binding of acetyl H3 in association with hTR expression. We confirm that the presence of the ALT phenotype is associated with poor prognosis and in addition, for the first time, we show a direct association between hTR expression and poor prognosis in liposarcoma patients.

KW - ALT

KW - Chromatin

KW - hTERT

KW - hTR

KW - Liposarcoma

KW - Telomerase

UR - http://www.scopus.com/inward/record.url?scp=42149110183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42149110183&partnerID=8YFLogxK

U2 - 10.1038/sj.bjc.6604328

DO - 10.1038/sj.bjc.6604328

M3 - Article

C2 - 18414473

AN - SCOPUS:42149110183

VL - 98

SP - 1467

EP - 1474

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 8

ER -